NEW YORK (GenomeWeb) – OncoDNA said today that it has signed a distribution agreement for its products in Morocco with diagnostic firm BioHisto Maroc.
Under the terms of the deal, BioHisto Maroc will market and distribute OncoDNA's suite of liquid biopsy and tissue-based genomic tests to oncologists and their patients. These include OncoDeep — a service that combines next-generation sequencing, fluorescence in situ hybridization, immunohistochemistry, and other approaches to analyze solid tumors — and newer liquid biopsy tests OncoTrace and OncoSelect.
"This agreement enables us to complete our product offering to oncologists with an extensive range of high-quality molecular diagnostic solutions," BioHisto Maroc General Manager Iman Alaoui Ismaili said in a statement.
OncoDNA has also signed several other distribution deals in recent months, including with Shchurko in Belarus, with Zogen in Mexico, and with Providens in Southern Europe.